Prospective comparison of simultaneous [68Ga]Ga-PSMA-11 PET/MR versus PET/CT in patients with biochemically recurrent prostate cancer-Reference-Cited by-同舟云学术

Prospective comparison of simultaneous [68Ga]Ga-PSMA-11 PET/MR versus PET/CT in patients with biochemically recurrent prostate cancer

Published:2021-08-10 Issue:2 Volume:32 Page:901-911
ISSN:0938-7994
Container-title:European Radiology
language:en
Short-container-title:Eur Radiol

Author:

Jentjens Sander^ORCID,Mai Cindy,Ahmadi Bidakhvidi Niloefar,De Coster Liesbeth,Mertens Nathalie,Koole Michel,Everaerts Wouter,Joniau Steven,Oyen Raymond,Van Laere Koen,Goffin Karolien

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00330-021-08140-0.pdf

Reference47 articles.

1. Stephenson AJ, Scardino PT, Kattan MW et al (2007) Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol 25:2035–2041. https://doi.org/10.1200/JCO.2006.08.9607

2. Heidenreich A, Bastian PJ, Bellmunt J et al (2014) U. European Association of, EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol 65:124–137. https://doi.org/10.1016/j.eururo.2013.09.046

3. Heidenreich A, Bastian PJ, Bellmunt J et al (2014) U. European Association of, EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol 65:467–479. https://doi.org/10.1016/j.eururo.2013.11.002

4. Suardi N, Gandaglia G, Gallina A et al (2015) Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years. Eur Urol 67:299–309. https://doi.org/10.1016/j.eururo.2014.02.011

5. Rigatti P, Suardi N, Briganti A et al (2011) Pelvic/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C]choline positron emission tomography/computed tomography. Eur Urol 60:935–943. https://doi.org/10.1016/j.eururo.2011.07.060

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Added Value of [18F]PSMA‐1007 PET/CT and PET/MRI in Patients With Biochemically Recurrent Prostate Cancer: Impact on Detection Rates and Clinical Management;Journal of Magnetic Resonance Imaging;2024-04-28

2. Assessment of PSMA Expression of Healthy Organs in Different Stages of Prostate Cancer Using [68Ga]Ga-PSMA-11-PET Examinations;Cancers;2024-04-16

3. Update on Positron Emission Tomography/Magnetic Resonance Imaging;Magnetic Resonance Imaging Clinics of North America;2023-11

4. Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial;European Journal of Nuclear Medicine and Molecular Imaging;2023-10-28

5. Pelvic PET/MR attenuation correction in the image space using deep learning;Frontiers in Oncology;2023-08-24